Ohio Considers Sensible Approach to Kratom Regulation Amid Safety Concerns

Ohio’s proposed ban on all forms of kratom has sparked debate among experts and advocates, as Gov. Mike DeWine urged scheduling all kratom compounds as controlled substances but made no distinction between natural leaf kratom and dangerous synthetic 7-hydroxymitragynine (7-OH) derivatives. The Ohio Board of Pharmacy has wisely postponed its decision, allowing time to evaluate crucial differences between natural kratom and potent synthetic variants.

While the FDA and states like Florida have moved to restrict concentrated synthetic 7-OH products, they have preserved access to natural leaf kratom, which has a much milder safety profile backed by extensive research and FDA clinical trials. Experts like Dr. C. Michael White urge Ohio to establish sensible regulations—age limits and 7-OH caps—to protect public health without a blanket ban. For full details, see the original article at the Canton Repository.